Supplementary Figure 10: Comparison of gene expression according to RHOA mutation status.
From: A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma
(a) Patients with wild-type RHOA (PAT1 and PAT3). (b) Patients with G17V RHOA (PAT2 and PAT4–PAT9).
